Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
Professor Xinan Sheng: Advancing ADC Sequencing Strategies to Overcome Drug Resistance
2026.01.24
Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
2026.01.23
Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
2026.01.23
2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
2026.01.20
2025 Tianjin International Breast Cancer Conference | Prof. Zhongsheng Tong: Targeted Therapy Frontiers and the “Tianjin Experience”
2026.01.20
2025 Yat-sen Breast Cancer Conference | Prof. Qiang Liu: Advancing Multidisciplinary Care for Breast Cancer in China
2026.01.20
2025 Yat-sen Breast Cancer Conference丨Professor Jing Yao: Addressing the Multiple Unique Needs of Young Breast Cancer Patients and Optimizing Treatment Choices Through Patient-Centered Care
2026.01.20
SABCS 2025 Insight Broadcast丨Professor Junjie Li: Exploring Precision Biomarkers for Neoadjuvant Therapy in HER2-Positive Breast Cancer
2026.01.20
SABCS 2025 Insight Broadcast: Professor Jin Yang: Interpreting the New Landscape of First-Line Advanced and Early Adjuvant Therapy for HR+/HER2− Breast Cancer
2026.01.20
SABCS Hot Commentary:Professor Xiaoyun Mao: A Breakthrough in “Intensified” First-Line Maintenance Therapy for HER2-Positive Metastatic Breast Cancer
2026.01.19
Posted inIOncology

Professor Xinan Sheng: Advancing ADC Sequencing Strategies to Overcome Drug Resistance

Posted by By Mourabit Halima 2026.01.24
Continue Reading
Posted inUroStream

Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment

Posted by By Mourabit Halima 2026.01.23
Continue Reading
CTI 2025 Exclusive Interview | Prof. Florent Malard

CTI 2025 Exclusive Interview | Prof. Florent Malard

Posted by By Mourabit Halima 2025.11.26
Read More
ESMO Interview | Dr. Bryan Li From Bladder Removal to Bladder Preservation: Perioperative Immunotherapy Reshapes MIBC Treatment

ESMO Interview | Dr. Bryan Li From Bladder Removal to Bladder Preservation: Perioperative Immunotherapy Reshapes MIBC Treatment

Posted by By Mourabit Halima 2025.11.26
Read More
CCHIO 2025丨Professor Tang Feifei: Diagnostic Challenges and Future Breakthroughs in Therapy-Related Myeloid Neoplasms

CCHIO 2025丨Professor Tang Feifei: Diagnostic Challenges and Future Breakthroughs in Therapy-Related Myeloid Neoplasms

Posted by By Mourabit Halima 2025.11.25
From November 6–9, 2025, the 2025 China Conference on Holistic Integrative Oncology (CCHIO) was held in Kunming. As one of the most influential oncology conferences in China, CCHIO gathered leading…
Read More
CCHIO 2025丨Professor Hui Zhou: Advancing Precision Lymphoma Care and System Development—Strategic Planning and Future Directions of the CACA Lymphoma

CCHIO 2025丨Professor Hui Zhou: Advancing Precision Lymphoma Care and System Development—Strategic Planning and Future Directions of the CACA Lymphoma

Posted by By Peng Longmei 2025.11.25
From November 6–9, 2025, the 2025 China Conference on Holistic Integrative Oncology (CCHIO) was grandly held in Kunming. As one of China’s largest and most influential oncology academic events, the…
Read More
Dr. Yishan Ye: Advancing Haploidentical Transplantation — Toward “Timely Access to Optimal Donors for All” | ICIC 2025

Dr. Yishan Ye: Advancing Haploidentical Transplantation — Toward “Timely Access to Optimal Donors for All” | ICIC 2025

Posted by By Mourabit Halima 2025.11.25
To promote innovation in China’s cell therapy and immunotherapy fields, advance discussion of key scientific challenges, share the latest clinical research, and strengthen global collaboration and translational progress, the 2025…
Read More
Expert Interview | Prof. Raynier DevillierTransplant Decision-Making and Donor Selection in Older Patients

Expert Interview | Prof. Raynier DevillierTransplant Decision-Making and Donor Selection in Older Patients

Posted by By Peter W. PENG 2025.11.25
Read More
Expert Interview | Prof. Mohamad Mohty Microbiota Modulation and New Strategies for Managing aGVHD

Expert Interview | Prof. Mohamad Mohty Microbiota Modulation and New Strategies for Managing aGVHD

Posted by By Mourabit Halima 2025.11.25
Read More
Expert Interview | Prof. Michael R. BishopAdvancing CAR-T Therapy: Earlier Use, Better Selection, and Next-Generation Strategies

Expert Interview | Prof. Michael R. BishopAdvancing CAR-T Therapy: Earlier Use, Better Selection, and Next-Generation Strategies

Posted by By Artie Zou (Lili Zou) 2025.11.25
Read More
Exclusive Interview | Prof. Edmund WallerInnovating CAR-T Therapy Through VIP Signaling Blockade

Exclusive Interview | Prof. Edmund WallerInnovating CAR-T Therapy Through VIP Signaling Blockade

Posted by By Mourabit Halima 2025.11.25
Read More
CTI 2025 | Interview with Prof. Yakoub-Agha Ibrahim

CTI 2025 | Interview with Prof. Yakoub-Agha Ibrahim

Posted by By Peter W. PENG 2025.11.25
Read More

Posts pagination

Previous page 1 … 19 20
Recent Posts
  • Professor Xinan Sheng: Advancing ADC Sequencing Strategies to Overcome Drug Resistance
  • Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
  • Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
  • 2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
  • 2025 Tianjin International Breast Cancer Conference | Prof. Zhongsheng Tong: Targeted Therapy Frontiers and the “Tianjin Experience”
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inIOncology
    Professor Xinan Sheng: Advancing ADC Sequencing Strategies to Overcome Drug Resistance
    Posted by By Mourabit Halima 2026.01.24
    Posted inUroStream
    Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
    Posted by By Mourabit Halima 2026.01.23
    Posted inUroStream
    Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
    Posted by By Mourabit Halima 2026.01.23
    Posted inIOncology
    2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
    Posted by By Mourabit Halima 2026.01.20
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied